Pharmaceutical stalwart Novo Nordisk (NVO) can’t seem to get anything good going these days. As TipRanks’ Vince Condarcuri ...

We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments’ Substack by Kontra. In this article, we ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Biopharmaceutical firms engaged in developing weight-loss drugs were rewarded rather significantly in 2024. It’s what helped ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20 percent of their body weight, on average, a result that caused the Danish company’s ...

It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.

Redevelopment and expansion of the St. Lucia Cruise Port has begun with an important demolition to clear space for new facilities. Cruise Hive readers have voted and Royal Caribbean’s Icon of ...

Novo Pharmaceuticals PVT LTD is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 5.0 lakhs and has ...

740.15 as on 31 Dec, 2024, 04:14 PM IST. On previous day, the Tata Motors Share Price (NSE) closed at Rs. 750.5, featuring among the most traded securities on the National Stock Exchange.